Regulation of peroxisome proliferator-activated receptor-γ expression in human eosinophils by estradiol

International Archives of Allergy and Immunology

Volumn 149, Issue SUPPL. 1, 2009, Pages 51-56

  Ueki, Shigeharu ^a   Oguma, Mariko ^a   Usami, Atsuko ^a   Kamada, Yumiko ^a   Kato, Hikari ^a   Kamada, Rie ^a   Takeda, Masahide ^a   Ito, Wataru ^a   Tanigai, Tomomi ^a   Kayaba, Hiroyuki ^a   Chihara, Junichi ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

Asthma; Eosinophils; Estradiol; PPAR ; Sex difference

Indexed keywords

ESTRADIOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; EOSINOPHIL; ESTRADIOL BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; FOLLICULAR PHASE; HUMAN; HUMAN CELL; MALE; MENSTRUAL CYCLE; MENSTRUATION; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEX DIFFERENCE;

ADULT; CELLS, CULTURED; EOSINOPHILS; ESTRADIOL; FEMALE; HUMANS; MALE; PPAR GAMMA; PREGNANCY; PROTEIN BIOSYNTHESIS; SEX FACTORS; UP-REGULATION;

EID: 67650222187     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210654     Document Type: Conference Paper

References (33)

1. Desvergne B, Wahli W: Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999;20:649-688.
2. Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA: Peroxisome proliferator-activated receptor-7:adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 1994;135:798-800.
3. Greene ME, Pitts J, McCarville MA, Wang XS, Newport JA, Edelstein C, Lee F, Ghosh S, Chu S: PPARγ: observations in the hematopoietic system. Prostaglandins Other Lipid Mediat 2000;62:45-73.
4. Ueki S, Mahemuti G, Oyamada H, Kato H, Kihara J, Tanabe M, Ito W, Chiba T, Takeda M, Kayaba H, Chihara J: Retinoic acids are potent inhibitors of spontaneous human eosinophil apoptosis. J Immunol 2008;181:7689-7698.
5. Ueki S, Adachi T, Bourdeaux J, Oyamada H, Yamada Y, Hamada K, Kanda A, Kayaba H, Chihara J: Expression of PPAR7 in eosinophils and its functional role in survival and chemotaxis. Immunol Lett 2003;86:183-189.
6. Matsuwaki Y, Ueki S, Adachi T, Oyamada H, Kamada Y, Yamaguchi K, Kanda A, Hamada K, Kayaba H, Chihara J: The synthetic PPARγ agonist troglitazone inhibits IL-5-induced CD69 upregulation and eosinophil-derived neurotoxin release from eosinophils. Pharmacology 2005;74:169-173.
7. Hirasawa H, Chiba T, Ueki S, Kamada Y, Ito W, Takeda M, Fujita M, Kato H, Kayaba H, Chihara J: The synthetic PPARγ agonist troglitazone inhibits eotaxin-enhanced eosinophil adhesion to ICAM-1-coated plates. Int Arch Allergy Immunol 2008;146(suppl 1): 11-15.
8. Woerly G, Honda K, Loyens M, Papin J, Au-werx J, Staels B, Capron M, Dombrowicz D: Peroxisome proliferator-activated receptor α and γ down-regulate allergic inflammation and eosinophil activation. J Exp Med 2003;198:411-421.
9. Trifilieff A, Bench A, Hanley M, Bayley D, Campbell E, Whittaker P: PPARαand-γ but not-β agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-κB-independent effect. Br J Pharmacol 2003;139:163-171.
10. Lee KS, Park SJ, Hwang PH, Yi HK, Song CH, Chai OH, Kim JS, Lee MK, Lee YC: PPARγ modulates allergic inflammation through up-regulation of PTEN. FASEB J 2005;19:1033-1035.
11. 2 prime eotaxin-in-duced chemotaxis on human eosinophils through peroxisome proliferator-activated receptor-γ ligation. J Immunol 2005;175:5744-5750.
12. Ueki S, Matsuwaki Y, Kayaba H, Oyamada H, Kanda A, Usami A, Saito N, Chihara J: Peroxisome proliferator-activated receptor-γ regulates eosinophil functions: a new therapeutic target for allergic airway inflammation. Int Arch Allergy Immunol 2004;134(suppl 1):30-36.
13. Fujita Y, Yamada Y, Kusama M, Yamauchi T, Kamon J, Kadowaki T, Iga T: Sex differences in the pharmacokinetics of pioglitazone in rats. Comp Biochem Physiol C Toxicol Pharmacol 2003;136:85-94.
14. Vidal-Puig AJ, Considine RV, Jimenez-Liñan M, Werman A, Pories WJ, Caro JF, Flier JS: Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 1997;99:2416-2422.
15. Ueki S, Usami A, Oyamada H, Saito N, Chiba T, Mahemuti G, Ito W, Kato H, Kayaba H, Chihara J: Procaterol upregulates peroxisome proliferator-activated receptor-γ expression in human eosinophils. Int Arch Allergy Immunol 2006;140(suppl 1):35-41.
16. Usami A, Ueki S, Ito W, Kobayashi Y, Chiba T, Mahemuti G, Oyamada H, Kamada Y, Fujita M, Kato H, Saito N, Kayaba H, Chihara J: Theophylline and dexamethasone induce peroxisome proliferator-activated receptor-γ expression in human eosinophils. Pharmacology 2006;77:33-37.
17. Chiba T, Kamada Y, Saito N, Oyamada H, Ueki S, Kobayashi Y, Kayaba H, Chihara J: RANTES and eotaxin enhance CD11b and CD18 expression on eosinophils from allergic patients with eosinophilia in the application of whole blood flow cytometry analysis. Int Arch Allergy Immunol 2005;137(suppl 1):12-16.
18. Gui Y, Cai Z, Silha JV, Murphy LJ: Variations in parametrial white adipose tissue mass during the mouse estrous cycle: relationship with the expression of peroxisome proliferator-activated receptor-γ and retinoic acid receptor-α. Can J Physiol Pharmacol 2006;84:887-892.
19. Ito I, Hayashi T, Yamada K, Kuzuya M, Naito M, Iguchi A: Physiological concentration of estradiol inhibits polymorphonuclear leukocyte chemotaxis via a receptor-mediated system. Life Sci 1995;56:2247-2253.
20. Stephens R, Eisenbarth SC, Chaplin DD: T helper type 1 cells in asthma: friend or foe? Curr Opin Allergy Clin Immunol 2002;2:31-37.
21. Kita H, Adolphson CR, Gleich GJ: Biology of eosinophils;in Adkinson NF, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FE (eds): Middleton's Allergy: Principles and Practice. Philadelphia, Mosby, 2003, pp 305-332.
22. Narala VR, Ranga R, Smith MR, Berlin AA, Standiford TJ, Lukacs NW, Reddy RC: Pioglitazone is as effective as dexamethasone in a cockroach allergen-induced murine model of asthma. Respir Res 2007;8:90.
23. Ibabe A, Herrero A, Cajaraville MP: Modulation of peroxisome proliferator-activated receptors (PPARs) by PPARα-and PPAR7-specific ligands and by 17β-estradiol in isolated zebrafish hepatocytes. Toxicol In Vitro 2005;19:725-735.
24. Zivadinovic D, Gametchu B, Watson CS: Membrane estrogen receptorαlevels in MCF-γ breast cancer cells predict cAMP and proliferation responses. Breast Cancer Res 2005;7:R101-R112.
25. Michael LF, Lazar MA, Mendelson CR: Peroxisome proliferator-activated receptor γ expression is induced during cyclic adenosine monophosphate-stimulated differentiation of alveolar type II pneumonocytes. Endocrinology 1997;138:3695-3703.
26. Barlier-Mur AM, Chailley-Heu B, Pinteur C, Henrion-Caude A, Delacourt C, Bourbon JR: Maturational factors modulate transcription factors CCAAT/enhancer-binding proteins α, β, δ, and peroxisome proliferator-activated receptor-γ in fetal rat lung epithelial cells. Am J Respir Cell Mol Biol 2003;29:620-626.
27. Nogueiras R, Caminos JE, Gallego R, Raghay K, Bravo S, Tovar S, Pombo C, Ĺpez M, Tena-Sempere M, García-Caballero T, Dié-guez C: Regulation of peroxisome proliferator activated receptor-γ in rat pituitary. J Neuroendocrinol 2005;17:292-297.
28. Gallo D, Zannoni GF, Fabrizi M, De Stefano I, Mantuano E, Scambia G: Comparative effects of 17β-estradiol and phytoestrogens in the regulation of endometrial functions in the rodent uterus. J Endocrinol Invest 2008;31:48-56.
29. Lundholm L, Zang H, Hirschberg AL, Gustafsson JA, Arner P, Dahlman-Wright K: Key lipogenic gene expression can be decreased by estrogen in human adipose tissue. Fertil Steril 2008;90:44-48.
30. Benayoun L, Letuve S, Druilhe A, Boczkowski J, Dombret MC, Mechighel P, Megret J, Leseche G, Aubier M, Pretolani M: Regulation of peroxisome proliferator-activated receptor γ expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. Am J Respir Crit Care Med 2001;164:1487-1494.
31. Kobayashi M, Thomassen MJ, Rambasek T, Bonfield TL, Raychaudhuri B, Malur A, Winkler AR, Barna BP, Goldman SJ, Kavuru MS: An inverse relationship between peroxisome proliferator-activated receptor γ and allergic airway inflammation in an allergen challenge model. Ann Allergy Asthma Immunol 2005;95:468-473.
32. Cardell LO, Hägge M, Uddman R, Adner M: Downregulation of peroxisome proliferator-activated receptors (PPARs) in nasal polyposis. Respir Res 2005;6:132.
33. Kang HJ, Cinn YG, Hwang SJ, Won Chae S, Woo JS, Lee SH, Lee HM: Up-regulation of peroxisome proliferator-activated receptor γ in perennial allergic rhinitis. Arch Otolaryngol Head Neck Surg 2006;132:1196-1200.